Quarterly report · Q1
9273.TEDINET S100SAN2
Period2023-07-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.8bn | 2023-07-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥22.1bn | 2022-07-01 → 2023-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.4bn | 2022-07-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥1.2bn | 2023-07-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥1.0bn | 2022-07-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.2bn | 2023-07-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥4.1bn | 2022-07-01 → 2023-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥979m | 2022-07-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.2bn | 2023-07-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥979m | 2022-07-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥758m | 2023-07-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.7bn | 2022-07-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥606m | 2022-07-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥758m | 2023-07-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥606m | 2022-07-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥28.7bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥28.5bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥26.3bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.4bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥7.5bn | at 2023-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥21.2bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥20.9bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥18.8bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.6bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.8bn | at 2023-06-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥19.12 | 2023-07-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.83 | 2022-07-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.29 | 2022-07-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 74.0% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.5% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.8% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2023-09-30 | −¥449m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2023-09-30 | −¥449m |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2023-09-30 | −¥15m |
| jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segment | revenue | 2023-07-01 → 2023-09-30 | ¥4.0bn |
| jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segment | revenue external | 2023-07-01 → 2023-09-30 | ¥3.6bn |
| jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segment | revenue intersegment | 2023-07-01 → 2023-09-30 | ¥449m |
| jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segment | segment profit | 2023-07-01 → 2023-09-30 | ¥686m |
| jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segment | revenue | 2023-07-01 → 2023-09-30 | ¥2.2bn |
| jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segment | revenue external | 2023-07-01 → 2023-09-30 | ¥2.2bn |
| jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segment | segment profit | 2023-07-01 → 2023-09-30 | ¥526m |
| —segment total | revenue | 2023-07-01 → 2023-09-30 | ¥6.3bn |
| —segment total | revenue external | 2023-07-01 → 2023-09-30 | ¥5.8bn |
| —segment total | revenue intersegment | 2023-07-01 → 2023-09-30 | ¥449m |
| —segment total | segment profit | 2023-07-01 → 2023-09-30 | ¥1.2bn |
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2022-09-30 | −¥501m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2022-09-30 | −¥501m |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2022-09-30 | ¥6m |
| jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥4.0bn |
| jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥3.5bn |
| jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥501m |
| jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥672m |
| jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥1.9bn |
| jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥1.9bn |
| jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥337m |
| —segment total | revenue | 2022-07-01 → 2022-09-30 | ¥5.9bn |
| —segment total | revenue external | 2022-07-01 → 2022-09-30 | ¥5.4bn |
| —segment total | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥501m |
| —segment total | segment profit | 2022-07-01 → 2022-09-30 | ¥1.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 346
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 1300 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | - | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 1300 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0000 | |
| Cash and deposits | Prior1YearInstant | 10767016000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 9574910000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 3910453000 | JPY |
| Notes and accounts receivable trade | CurrentQuarterInstant | 4219983000 | JPY |
| Electronically recorded monetary claims operating ca | Prior1YearInstant | 4406195000 | JPY |
| Electronically recorded monetary claims operating ca | CurrentQuarterInstant | 5213939000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 1415639000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 1514914000 | JPY |
| Work in process | Prior1YearInstant | 563125000 | JPY |
| Work in process | CurrentQuarterInstant | 491750000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 483358000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 545339000 | JPY |
| Other ca | Prior1YearInstant | 284469000 | JPY |
| Other ca | CurrentQuarterInstant | 296443000 | JPY |
| Current assets | Prior1YearInstant | 21830258000 | JPY |
| Current assets | CurrentQuarterInstant | 21857281000 | JPY |
| Buildings and structures | Prior1YearInstant | 4889478000 | JPY |
| Buildings and structures | CurrentQuarterInstant | 4897723000 | JPY |
| Accumulated depreciation buildings and structures | Prior1YearInstant | -2336069000 | JPY |
| Accumulated depreciation buildings and structures | CurrentQuarterInstant | -2385200000 | JPY |
| Buildings and structures net | Prior1YearInstant | 2553408000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 2512522000 | JPY |
| Machinery equipment and vehicles | Prior1YearInstant | 3798624000 | JPY |
| Machinery equipment and vehicles | CurrentQuarterInstant | 3804129000 | JPY |
| Accumulated depreciation machinery equipment and vehicles | Prior1YearInstant | -2267079000 | JPY |
| Accumulated depreciation machinery equipment and vehicles | CurrentQuarterInstant | -2366005000 | JPY |
| Machinery equipment and vehicles net | Prior1YearInstant | 1531544000 | JPY |
| Machinery equipment and vehicles net | CurrentQuarterInstant | 1438123000 | JPY |
| Tools furniture and fixtures | Prior1YearInstant | 1351945000 | JPY |
| Tools furniture and fixtures | CurrentQuarterInstant | 1354353000 | JPY |
| Accumulated depreciation tools furniture and fixtures | Prior1YearInstant | -1085743000 | JPY |
| Accumulated depreciation tools furniture and fixtures | CurrentQuarterInstant | -1105783000 | JPY |
| Tools furniture and fixtures net | Prior1YearInstant | 266201000 | JPY |
| Tools furniture and fixtures net | CurrentQuarterInstant | 248569000 | JPY |
| Land | Prior1YearInstant | 1761774000 | JPY |
| Land | CurrentQuarterInstant | 1761774000 | JPY |
| Construction in progress | Prior1YearInstant | 163026000 | JPY |
| Construction in progress | CurrentQuarterInstant | 485414000 | JPY |
| Property plant and equipment | Prior1YearInstant | 6275955000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 6446405000 | JPY |
| Other ia | Prior1YearInstant | 33879000 | JPY |
| Other ia | CurrentQuarterInstant | 28237000 | JPY |
| Intangible assets | Prior1YearInstant | 33879000 | JPY |
| Intangible assets | CurrentQuarterInstant | 28237000 | JPY |
| Investment securities | Prior1YearInstant | 56775000 | JPY |
| Investment securities | CurrentQuarterInstant | 71372000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |